SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q/A
/ X / Quarterly Report pursuant to Section 13 or 15(d)
----
of the Securities Exchange Act of 1934
For the quarterly period ended October 31, 2002.
or
/ / Transition Report pursuant to Section 13 or 15(d)
----
of the Securities Exchange Act of 1934
For the transition period from _____ to _____.
Commission file number: 0-6132
CANTEL MEDICAL CORP.
(Exact name of registrant as specified in its charter)
DELAWARE 22-1760285
------------------------------- --------------------
(State or other jurisdiction of (I.R.S. employer
incorporation or organization) identification no.)
150 CLOVE ROAD, LITTLE FALLS, NEW JERSEY 07424
------------------------------------------------------------------
(Address of principal executive offices) (Zip code)
Registrant's telephone number, including area code
(973) 890-7220
Indicate by check mark whether registrant (1) has filed all reports required to
be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to the filing
requirements for the past 90 days. Yes X No
----- -----
Number of shares of Common Stock outstanding as of December 6, 2002: 9,263,503.
EXPLANATORY NOTE
This amendment to Form 10-Q of Cantel Medical Corp. for the quarter
ended October 31, 2002 filed on December 16, 2002 is being filed solely for the
purpose of filing certifications pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, which were inadvertently omitted in the December 16, 2002 filing.
PART II - OTHER INFORMATION
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
(a) Exhibits:
99.1 - Certification pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002.
99.2 - Certification pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002.
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
CANTEL MEDICAL CORP.
Date: December 30, 2002
By: /s/ JAMES P. REILLY
------------------------
James P. Reilly, President
and Chief Executive Officer
(Principal Executive Officer)
By: /s/ CRAIG A. SHELDON
------------------------
Craig A. Sheldon, Senior Vice
President and Chief Financial
Officer (Principal Financial and
Accounting Officer)
2